Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$LCTX

Lineage Cell Therapeutics, Inc.

XASE

$1.11+0.90%+$0.0099Prev $1.10LIVE Full chart Live alerts
No recent price bars, the chart lights up when LCTX starts printing.

Why is LCTX up today? It is at $1.11 (+0.00%), and our scanner flagged it 6 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LCTX spikes, and full due diligence on LCTX — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $LCTX alerts the moment volume spikes

Our scanner flagged $LCTX 6 times in the last 30 days. Create a free account to track $LCTX, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$1.11
Change today
+0.00%
Previous close
$1.10
52-week range
$0.930 – $2.09
Valuation & dividend
Market cap
$289M
Ownership & volume
Shares outstanding
249.3M
SEC · as of 2026-05-08
Insider ownership
26.2%
DEF 14A · 2026-04-29
Institutional own.
50.50%
Total held
76.7%
Tradeable float
58.1M
23% of shares · after 26% insiders + 51% institutions
Short interest
28.2M
▲ +10% vs prior · as of 2026-06-30
Short % of float
48.5%
Days to cover
8.3d
Avg daily volume
1.5M
Next earnings
Aug 11 · in 21d
Classification
Exchange
XASE

Get free LCTX + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $LCTX moving today?

Here is the latest on LCTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LCTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Likely catalystOther Material Event · Shareholder Vote, from the latest SEC filing. Read it →
Why is $LCTX moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile🔥 Heavily shorted · 49% of floatShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy4 analysts
Avg target $7.00(+531% upside)
Range $3 – $9
4 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

1 open-market buy0 buys, 0 sells last 3 months (3/4 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Culley Brian M
Officer
Bought (open market)+15Kadded 6.2%256K$24K
at $1.62
Mar 12, 26
Culley Brian M
Officer
Sold (automatic/other)-13Ksold 5.1%241K$23K
at $1.80
Feb 11, 26
Culley Brian M
Officer
Other31K
0.01% of company
added 14%253Kn/aFeb 11, 26
Samuel George A. Iii
Officer
Sold (automatic/other)-3Ksold 7.5%31K$5K
at $1.80
Feb 11, 26
Samuel George A. Iii
Officer
Other6Kadded 22%34Kn/aFeb 11, 26
Samuel George A. Iii
Officer
Acquired (grant/award)+2Kadded 6.7%28Kn/aDec 19, 25
Samuel George A. Iii
Officer
Sold (automatic/other)-65sold 0.2%27K$109
at $1.68
Dec 19, 25
Culley Brian M
Officer
Acquired (grant/award)+9Kadded 4.2%222Kn/aDec 19, 25
Culley Brian M
Officer
Sold (automatic/other)-334sold 0.2%222K$561
at $1.68
Dec 19, 25
Culley Brian M
Officer
Sold (automatic/other)-13Ksold 5.5%214K$8K
at $0.650
Feb 11, 25
Culley Brian M
Officer
Other31K
0.01% of company
added 16%226Kn/aFeb 11, 25
Samuel George A. Iii
Officer
Sold (automatic/other)-2Ksold 8.6%26K$2K
at $0.650
Feb 11, 25

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Active shelf

Recent share offering + active shelf on file — the company raised capital and can raise more. If $LCTX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$LCTX Sentiment

Bullish
Bearish81Bullish
📰 News: 3 bull · 0 bearToday: +0.9%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$LCTX Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 15h ago 92.3× RVOL
LCTX hit 92.278x RVOL at 3:02 PM ET
at $1.11
Alert· 16h ago -0.9% vs EMA
$LCTX near 200 EMA: -0.90% from 200 EMA at 1:51 PM ET
at $1.10
Alert· 16h ago +2.27%
$LCTX moved +2.27% in 1 min (Level 1) at 1:51 PM ET
at $1.11
Alert· 16h ago 49.0× RVOL
LCTX hit 49.041x RVOL at 1:51 PM ET
at $1.10
Alert· 19h ago +1.36%
$LCTX moved +1.36% in 1 min (Level 1) at 11:33 AM ET
at $1.11
Alert· 19h ago -2.6% vs EMA
$LCTX near 200 EMA: -2.57% from 200 EMA at 11:33 AM ET
at $1.11
Alert· 19h ago 54.3× RVOL
LCTX hit 54.306x RVOL at 11:33 AM ET
at $1.11
Alert· 19h ago 4.4× RVOL
LCTX hit 4.412x RVOL at 11:13 AM ET
at $1.11
News· SEC EDGAR· 38d ago
Lineage Cell Therapeutics, Inc. filed an 8-K: Shareholder Vote, Other Material Event
News· Benzinga· 61d ago Bullish
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
News· SEC EDGAR· 69d ago
Lineage Cell Therapeutics, Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 69d ago
Lineage Cell Therapeutics, Inc. filed an 8-K: Results of Operations
News· Benzinga· 101d ago Bullish
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
News· Benzinga· 124d ago Neutral
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
News· SEC EDGAR· 131d ago
Lineage Cell Therapeutics, Inc. filed an 8-K: Other Material Event
News· Benzinga· 172d ago Bullish
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

LCTX stock FAQ

Why is $LCTX moving today?

Here is the latest on LCTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LCTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the LCTX stock price today?

LCTX last traded at $1.11, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does LCTX report earnings?

Lineage Cell Therapeutics, Inc. (LCTX) is next expected to report earnings on Tuesday, August 11, 2026, about 21 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live LCTX alerts?

The LCTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LCTX 6 times in the last 30 days.

What exchange is LCTX on?

LCTX (Lineage Cell Therapeutics, Inc.) trades on XASE, with a market cap of about $289M.

Is LCTX good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LCTX for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.